SCHEMBL30179980

SCHEMBL30179980

OCCOc1ccc(-c2ccc(OCc3ccccc3)nc2OCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ LTA4H P09960 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ MAPT P10636 4/20 0.43
▸ NPSR1 Q6W5P4 4/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24847986 1.00 GSTP1 (0.47) GSTP1ALDH1A1RECQLLTA4HEPHX2
SCHEMBL28969675 0.88 FFAR4 (0.51) GSTP1
SCHEMBL31171204 0.88 GSTP1 (0.43) GSTP1LTA4HEPHX2LMNAMAPT
SCHEMBL24207230 0.86 LMNA (0.47) GSTP1LMNACYP1A2PTGS1SLC6A2
SCHEMBL28969658 0.86 LTB4R (0.47) HDAC6
SCHEMBL24206861 0.85 CYP4F2 (0.44) GSTP1LTA4HEPHX2TDP1GRM5
SCHEMBL30151511 0.85 CYP4F2 (0.44) GSTP1LTA4HEPHX2TDP1GRM5
SCHEMBL26641259 0.85 GRM5 (0.43) GSTP1GRM5SQOR
SCHEMBL26093766 0.84 ACACB (0.42) GSTP1ALDH1A1LTA4HEPHX2MAOB
SCHEMBL30817355 0.83 LTA4H (0.56) GSTP1LTA4HEPHX2GRM5SQOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120092003-A CDK protein degrading agents, pharmaceutical compositions and therapeutic uses 拜欧斯瑞克斯公司 2025-06-03 — — CN disclosed
WO-2023278759-A1 MK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-01-05 — — WO disclosed
Send feedback